Search Within

Stephen D Nimer

Formats
  1. Journal Article (181)
  2. Meeting Abstract (162)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (347)
  2. Hematologic Malignancies, Division of (347)
  3. Center for Hematologic Malignancies (121)
  4. Adult Leukemia (57)
  5. GSK Faculty (56)
  6. Survivorship Research (50)

More Groups

People
  1. Craig Moskowitz (46)
  2. Andrew Zelenetz (40)
  3. Tarun Kewalramani (40)
  4. Raymond Comenzo (36)
  5. Hani Hassoun (31)
  6. Virginia Klimek (30)

More People

Years
  1. 2017 (1)
  2. 2014 (3)
  3. 2013 (8)
  4. 2012 (19)
  5. 2011 (24)
  6. 2010 (17)

More Years

Publications
  1. Blood (175)
  2. Cancer Research (12)
  3. Oncogene (9)
  4. British Journal of Haematology (8)
  5. Leukemia Research (8)
  6. Bone Marrow Transplantation (7)

More Publications

Publishers
  1. American Society of Hematology (176)
  2. Nature Publishing Group (29)
  3. American Association for Cancer Research (19)
  4. Elsevier Inc. (12)
  5. Cell Press (11)
  6. John Wiley & Sons (9)

More Publishers

Results (347)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
    Journal Article

    Gupta, S.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Reich, L.; Costello, S.; Drake, L.; Klimek, V.; Dhodapkar, M.; Teruya-Feldstein, J.; more...
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma
    Meeting Abstract

    Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • The utility of consolidative upfront high dose chemoradiotherapy and ASCT in patients with mantle cell lymphoma (MCL)
    Meeting Abstract

    Persky, Daniel; Portlock, Carol S.; Lessac-Chenen, Simone; Iasonos, Alexia; Zelenetz, Andrew D; Kewalramani, Tarun; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • MEF regulates the growth of ovarian cancer cells
    Meeting Abstract

    Yao, J.; Hedvat, C. V.; Nimer, S. D.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Arginine methylation of Runx1 regulates its biological and transcriptional activities
    Meeting Abstract

    Zhao, X. Y.; Pardanani, A.; Zhang, J.; Dunne, R.; Xiao, A.; Allis, C. D.; Nimer, S.
    Blood (2004)

    Fulltext@MSK | Save
  • The importance of molecular phenotype in predicting overall survival in patients with relapsed or primary refractory DLBCL treated with second-line chemotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Hamlin, P.; Nimer, S. D.; Zelenetz, A. D.; Teruya-Feldstein, J.
    Blood (2004)

    Fulltext@MSK | Save
  • MEF regulates hematopoietic stem cell quiescence and hematologic recovery post-myelosuppression
    Meeting Abstract

    Lacorazza, H. D.; Nunes, J.; Nimer, S. D.
    Experimental Hematology (2004)

    Fulltext@MSK | Save
  • Clinical course and significance of the novel FLT3-Y842C mutation in a patient with AML treated with PKC412 monotherapy
    Meeting Abstract

    Kindler, T.; Breitenbuecher, F.; Kasper, S.; Estey, E.; Giles, F.; Feldman, E.; Ehninger, G.; Schiller, G.; Klimek, V.; Nimer, S. D.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Serum IL-12 : IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Tuma, R. A.; Almyroudis, N. G.; Sohn, S.; Rice, R. D.; Galinkin, D.; Blain, M.; Qin, J.; Pamer, E. G.; Nimer, S. D.
    Blood (2004)

    Fulltext@MSK | Save
  • Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML
    Meeting Abstract

    Heidel, F.; Breitenbuecher, F.; Kindler, T.; Solem, F. K.; Carius, B.; Thiede, H. M.; Cohen, P. S.; Roesel, J.; Estey, E. H.; Feldman, E.; more...
    Blood (2004)

    Fulltext@MSK | Save